Skip to main content
. Author manuscript; available in PMC: 2015 Jan 8.
Published in final edited form as: J Endocrinol Diabetes Obes. 2014 Oct;2(4):1057.

Table 4.

Incidence of severe adverse events, safety population.

D-tagatose 2.5g
N = 52
n (%)
D-tagatose 5.0g
N = 46
n (%)
D-tagatose 7.5g
N = 47
n (%)
Total
N = 145
n (%)
Nausea - - 1 (2.1%) 1 (0.7%)
Retching - - 1 (2.1%) 1 (0.7%)
Vomiting 1 (1.9%) - - 1 (0.7%)
Fatigue - 1 (2.2%) - 1 (0.7%)
Lethargy - 1 (2.2%) - 1 (0.7%)
Anxiety 1 (1.9%) - - 1 (0.7%)